Endogenous RNA is central to protein control and, ultimately, cellular function. Synthetic RNA is an important tool for biological research and is also offering a new generation of promising ...

Dipti Mehta has worked as a Senior Application Scientist at Revvity since 2022. Her research in DNA and protein assay development with LabChip GX Touch technology has generated new commercial assays.

Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...

Outside the United States, the therapeutic community (TC) model is widely embraced, with currently 65 countries offering treatments and over 3,000 TC models incorporated into community settings across ...

Cancer remains one of the most challenging diseases to treat due to its complexity and tendency to metastasize (spread into or invade, nearby tissues or distant places in the body to form new tumors).

A version of this story appeared in Volume 103, Issue 11 Chemists and chemical biologists just keep dreaming up new ways to interfere with biomolecules. That research frequently leads to promising ...

Professor Susan Sharfstein (University at Albany) discusses advances in cell line development, from high-throughput screening to transcription-based selection. Maren Grün (Thermo Fisher Scientific) sh ...